Back to search
Stage III Uterine Corpus Leiomyosarcoma AJCC v8
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Stage III Uterine Corpus Leiomyosarcoma AJCC v8 trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Stage III Uterine Corpus Leiomyosarcoma AJCC v8 trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This phase II trial studies olaparib and temozolomide in treating patients with uterine leiomyosarcoma (LMS) that may have spread from where it first started to…
This phase II/III trial compares the effect of the combination treatment with olaparib and temozolomide to trabectedin or pazopanib (two of the most common chem…
This phase II trial studies how well cabozantinib and temozolomide work in treating patients with leiomyosarcoma or other soft tissue sarcoma that cannot be rem…
This phase I/II trial studies the side effects and best dose of sapanisertib and to see how well it works compared to pazopanib hydrochloride in treating patien…